Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels

Ibiye Owei, Nkiru Umekwe, Fatoumatta Ceesay and Samuel Dagogo-Jack
The Journal of the American Board of Family Medicine January 2019, 32 (1) 20-27; DOI: https://doi.org/10.3122/jabfm.2019.01.180242
Ibiye Owei
From Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN.
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nkiru Umekwe
From Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatoumatta Ceesay
From Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN.
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Dagogo-Jack
From Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Lifestyle intervention decreases diabetes risk in prediabetic subjects, but the impact of passive notification of prediabetes status on glycemia or health behavior is unclear.

Methods: The Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) study followed normoglycemic African American (AA) and European American (EA) offspring of parents with type 2 diabetes mellitus for incident prediabetes. During 5.5 years of follow-up (mean, 2.62 years), 101 of 343 subjects developed prediabetes and were notified, without any interventions. Participants were recalled 18 months poststudy. Here, we compared data from participants with incident prediabetes or normoglycemia (control) during POP-ABC who underwent retesting 18-months poststudy.

Results: There were 73 subjects (46 female, 27 male; 36 AA, 37 EA) in the prediabetes group and 73 subjects (48 female, 25 male; 35 AA, 38 EA) in the control group. The mean (± SEM) enrollment age was 48.7 ± 0.96 years versus 48.3 ± 1.06 years (P = .37) and body mass index (BMI) was 31.1 ± 0.70 kg/m2 versus 29.2 ± 0.69 kg/m2 (P = .04) for prediabetes versus control groups, respectively. The 18-month changes (prediabetes vs control) were the following: fasting plasma glucose (FPG), −8.01 ± 1.11 vs 2.02 ± 0.64 mg/dL; 2-hour plasma glucose (2hrPG), −8.21 ± 3.34 vs 8.53 ± 3.17 mg/dL; weight, −0.54 ± 0.72 vs 2.77 ± 1.25 kg; and waist circumference −1.07 ± 0.78 vs 1.78 ± 0.85 (P = .03-<0.0001). The interval changes in FPG were significantly correlated with changes in weight and waist circumference (r = 0.2, P = .01). The prediabetes group reported improved dietary and exercise habits compared with control.

Conclusion: Communication of prediabetes status is associated with improvements in glucose tolerance, glycemia, and adiposity, probably via self-directed lifestyle modification.

  • Health Behavior
  • Life Style
  • Prediabetes

The Department of Health and Human Services (HHS) and the American Diabetes Association (ADA) drew attention to prediabetes at a joint press conference: “HHS and the ADA are using the new term ‘prediabetes’ to describe an increasingly common condition in which blood glucose levels are higher than normal but not yet diabetic—known in medicine as impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). Studies have shown that most people with this condition go on to develop type 2 diabetes within 10 years.”1 The Centers for Disease Control and Prevention estimates that 84.1 million US adults aged 18 years or older (∼34% of the adult US population) had prediabetes in 2015.2 Worldwide, more than 300 million people are estimated to have prediabetes.3

The diagnosis of prediabetes is established by the documentation of IFG, indicated by a fasting plasma glucose (FPG) level of 100 mg/dL to 125 mg/dL (5.6–6.9 mmol/L) or IGT, indicated by a 2-hour plasma glucose (2hrPG) level of 140 mg/dL to 199 mg/dL (7.8–11.0 mmol/L) during a 75-g oral glucose tolerance test (OGTT).4,5 Hemoglobin A1c (HbA1c) levels of 5.7–6.4% are also diagnostic of prediabetes.4 Besides the risk of developing type 2 diabetes mellitus (T2DM), people with prediabetes are at increased risks for heart disease, stroke, neuropathy, and other microvascular complications.6⇓–8

Several landmark clinical trials have demonstrated that lifestyle modification decreases blood glucose levels and prevents progression to T2DM in persons with prevalent prediabetes.9,12 In those studies, teams of dietitians, exercise physiologists, and other clinicians executed the standard lifestyle intervention protocols that led to the improvement in glucose tolerance and successful prevention of T2DM in study participants.9,11,13 Compared with the placebo group, individuals assigned to lifestyle intervention experienced 40–58% relative reduction in the risk of developing T2DM.9,11 Notably, the participants in the landmark diabetes prevention studies all had prevalent prediabetes determined during cross-sectional population screening and, therefore, of unknown duration at enrollment.9⇓–11

The impact of awareness of incident prediabetes status on glycemic trajectories among previously normoglycemic persons is unknown, and cross-sectional surveys show conflicting reports regarding the impact of such awareness on self-directed health behavior.14,15 The Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC)16,17 study enrolled normoglycemic African American (AA) and European American (EA) offspring of parents with T2DM and followed them for the occurrence of incident prediabetes, defined as IFG and/or IGT.4,5 All POP-ABC study participants completed a screening OGTT before enrollment. The first subject was enrolled in September 2006, and the POP-ABC study ended in February 2012 after the final follow-up visits. During ∼5 years of follow-up, 101 of 343 subjects developed prediabetes and were duly notified, without any active intervention or counseling, as POP-ABC was a natural history study.

Eighteen months after the study ended, POP-ABC study participants were invited to return for OGTT and clinical examination, as part of the screening procedures for a newly funded Pathobiology and Reversibility of Prediabetes in A Biracial Cohort (PROP-ABC) study, whose aims include intensive lifestyle intervention to reverse prediabetes (ClinicalTrials.gov Identifier NCT02027571). Here, we report temporal changes in glucose and other metabolic measures between the end of POP-ABC and the beginning of PROP-ABC (18 months later) in participants with incident prediabetes during POP-ABC (pre-diabetes mellitus group) compared with a matched group of POP-ABC participants who did not develop prediabetes.

Methods

Study Subjects

The study subjects were participants in the POP-ABC study.16,17 Eligibility criteria for the POP-ABC study included age 18 to 65 years, self-reported non-Hispanic white (EA) or non-Hispanic black (AA) race/ethnicity status; 1 or both biological ]parents with T2DM; no evidence of diabetes; normal FPG (<100 mg/dL [<5.6 mmol/L]) and/or normal 2hrPG (<140 mg/dL [<7.8 mmol/L]) during a 75-g OGTT; and good overall health, as previously described.16,17 None of the participants was using any medications known to alter glucose or lipid metabolism. Enrollment in behavioral, pharmacologic, or other active weight loss program or a history of liposuction or bariatric surgery were additional exclusion criteria.16,17 The primary outcome was the occurrence of prediabetes (IFG and/or IGT) or diabetes, defined by the ADA criteria.4 A confirmatory test was performed within 6 weeks of each endpoint occurrence. The 75-g OGTT was the method of confirmation. All endpoints were independently adjudicated by the Institutional Data and Safety Officer (Murray Heimberg, MD, PhD). The study protocols were approved by the University of Tennessee Institutional Review Board; all participants gave written informed consent before initiation of study procedures.

Chronology and Outcome

The first subject was enrolled in September 2006 and the POP-ABC study ended in February 2012 after the final follow-up visits.16,17 During 5.5 years of follow-up (mean, 2.62 years), 101 of 343 participants developed incident prediabetes.17 Per the study protocol, a copy of the confirmatory OGTT result was provided to all participants reaching the endpoint. However, no intervention or counseling was provided, as POP-ABC was a purely natural history study. In September 2013, 18 months after close-out of the POP-ABC study, funding became available for a continuation study, the PROP-ABC, whose goal is to provide intensive lifestyle intervention to the POP-ABC participants with incident prediabetes (ClinicalTrials.gov Identifier NCT02027571). Eligibility for PROP-ABC thus was limited to the original POP-ABC participants, all of whom were invited to join the new study. Interested participants underwent a standard OGTT, anthropometry, and clinical examination, as part of the baseline reenrollment procedures. To test the hypothesis that awareness of incident prediabetes status triggers self-directed health behaviors that improve metabolic endpoints, we compared the temporal trends in OGTT, anthropometric, and lipid data between the end of POP-ABC and the initiation of PROP-ABC study in participants with incident prediabetes during the POP-ABC phase and an age-, sex-, and ethnicity-matched control group. We also compared changes in self-reported dietary and physical activity behaviors between the 2 groups of participants.

Figure 1 summarizes the time intervals from the beginning until the end of the POP-ABC study to rescreening for the extension PROP-ABC study.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Study design and time intervals of data collection. Prediabetes outcome was assessed after ∼5 years of follow-up of initially normoglycemic POP-ABC participants. Eighteen months later, POP-ABC study participants were rescreened for a newly funded extension PROP-ABC study. The present report compares the 18-month interval changes in glycemic and other measurements between participants who developed prediabetes during POP-ABC study and those who remained normoglycemic.

Assessments

Participants arrived at the University of Tennessee General Clinical Research Center after an overnight fast to undergo physical examination and scheduled assessments. Height was recorded using a stadiometer, weight was measured with a digital scale (Tanita WB-300 Plus Digital, Arlington Heights, IL), and body mass index (BMI) was calculated as weight (kg) divided by the square of the height in meters. A Gulick II tape was used to measure waist circumference, as previously described.16,17 Usual food intake was captured using the Food Habits Questionnaire (FHQ)18 and habitual physical activity was recorded using the Modifiable Activity Questionnaire (MAQ),19 as previously described.20 The responses to the MAQ were converted to metabolic equivalent (MET) based on the intensity of the reported activities and expressed as MET-hours/week.20 A standard OGTT was initiated between 0700 and 1100: venous blood specimens for glucose and insulin measurement were obtained before (0 minutes) and at 30 minutes and 120 minutes after ingestion of 75 g flavored glucose (Trutol 75; Custom Laboratories, Baltimore, MD).

Biochemical Measurements

Plasma glucose was measured with a glucose oxidase method (Yellow Spring Instruments Co., Inc., Yellow Spring, OH). Plasma insulin levels were measured immunochemically in our Endocrine Research Laboratory, using commercial enzyme-linked immunosorbent assay kits. HbA1c and fasting plasma lipid profiles were measured in a contract clinical laboratory.

Statistical Analysis

Data were reported as means ± SEM. Differences between defined groups were analyzed using unpaired t tests for continuous variables and χ2 test for categoric variables. Interval changes in glycemic, anthropometric, and behavioral measures between the 2 defined testing periods were analyzed using paired t tests. General linear regression models were used to analyze the relationship between temporal changes in anthropometric and metabolic variables. All statistical analyses were performed with the use of SAS statistical software, version 9.3 (SAS Institute Inc., Cary, NC).

Results

Cohort Description

The characteristics at enrollment of study subjects who developed prediabetes and were so informed during POP-ABC and age- and sex-matched participants who maintained normoglycemia during POP-ABC study (control) are shown in Table 1. As previously reported,17 participants who developed incident prediabetes had higher BMI, waist circumference, FPG, and 2hrPG at enrollment, compared with participants who maintained normoglycemia.

View this table:
  • View inline
  • View popup
Table 1.

Baseline Characteristics of Pathobiology of Prediabetes in a Biracial Cohort Study Participants Who Subsequently Developed Incident Prediabetes or Maintained Normoglycemia (Control) during ∼5 Years of Follow-up*

Glycemic, Anthropometric, and Lipidmic Changes

We assessed the interval changes in plasma glucose and other metabolic endpoints when progressors and nonprogressors to prediabetes during POP-ABC study were rescreened for enrollment in the extension study (PROP-ABC). As already noted, the POP-ABC study was an observational, natural history study that did not entail any drug intervention or lifestyle counseling to alter metabolic endpoints. During the 18-month interval between the end of POP-ABC study and rescreening for the PROP-ABC study, FPG levels decreased by 8.01 ± 1.11 mg/dL in the prediabetes group and by 2.02 ± 0.64 mg/dL in the control group (P < .0001). During the same said interval, 2hrPG levels decreased by 8.21 ± 3.34 mg/dL in the prediabetes group but increased by 8.53 ± 3.17 mg/dL in the control group (P = .0004) (Figure 2 and Table 2). The corresponding interval changes (prediabetes group vs control group) were −0.54 ± 0.72 kg versus 2.77 ± 1.25 kg (P = .006) for body weight and −1.07 ± 0.78 cm versus 1.78 ± 0.85 cm (P = .001) for waist circumference (Figure 2 and Table 2). The change in BMI was 0.23 ± 0.29 kg/m2 in the prediabetes group and 1.06 ± 0.46 kg/m2 in control (P = .03). In the regression analyses, the interval changes in FPG were correlated with interval changes in weight (r = 0.18, P = .04) and waist circumference (r = 0.20, P = .01).

Figure 2.
  • Download figure
  • Open in new tab
Figure 2.

Interval changes in glycemia in prediabetes and control groups (A) and within the prediabetes group by ethnicity (B), and interval changes in weight (C) and waist circumference (D) in the prediabetes and control groups. There were no significant ethnic differences in the interval changes in glycemia. *P = .006, **P = .001, ***P = .0004, ****P < .0001. To convert the values for glucose to millimoles per liter, multiply by 0.0555. FPG, fasting plasma glucose; PG, plasma glucose.

View this table:
  • View inline
  • View popup
Table 2.

Interval Changes in Glycemic, Anthropometric and Behavioral Measures in Subjects with Incident Prediabetes or Normoglycemia (Control)*

The prediabetes group did not show significant alterations in plasma levels of low-density lipoprotein cholesterol (111 ± 3.61 mg/dL vs 111 ± 3.79 mg/dL), high-density lipoprotein cholesterol (49.2 ± 2.18 mg/dL vs 50.5 ± 1.65 mg/dL), or triglycerides (106 ± 6.71 mg/dL vs 102 ± 5.33 mg/dL) between the end of POP-ABC versus follow-up examination 18 months later, nor did the control group: low-density lipoprotein cholesterol, 106 ± 3.55 mg/dL versus 106 ± 3.31 mg/dL; high-density lipoprotein cholesterol, 54.7 ± 1.73 mg/dL versus 55.1 ± 1.57 mg/dL; and triglycerides, 91.5 ± 5.85 versus 94.2 ± 4.91.

Behavioral Changes

Self-reported FHQ score (lower values indicate healthier eating pattern) decreased from 2.57 ± 0.51 to 2.34 ± 0.55 (−0.23; P = .0003) in the prediabetes group and from 2.51 ± 0.50 to 2.35 ± 0.52 (−0.16; P = .0005) in the control group. The absolute decrease in FHQ score was significantly greater in the prediabetes group versus control group (−0.23 ± 0.05 vs −0.16 ± 0.04, P = .002). Self-reported MAQ score (higher values indicate greater physical activity) increased nominally from 13.8 ± 3.03 MET-hr/wk to 16.5 ± 2.47 MET-hr/wk in the prediabetes group, but decreased nominally from 21.7 ± 3.39 MET-hr/wk to 18.4 ± 2.76 MET-hr/wk in the control group. The absolute change in MAQ score was significantly greater in the prediabetes group versus control group (2.70 ± 3.45 MET-hr/wk vs −3.30 ± 4.20 MET-hr/wk; P = .002) (Table 2).

Discussion

In the present report, we observed that POP-ABC participants who were notified that they had developed incident prediabetes showed decreases in FPG and 2hrPG levels, weight, and waist circumference when reassessed 18 months later. These improvements were in comparison with a control group of age-, sex-, and ethnicity-matched POP-ABC participants who had maintained normoglycemia during the same follow-up period. The POP-ABC study was a longitudinal natural history study of the transition from normal glucose regulation to prediabetes among initially normoglycemic AA and EA adults who have 1 or both biological parents with diagnosed T2DM.16,17 By design, no therapeutic intervention was offered to the participants who progressed to prediabetes. However, a written report of the confirmatory OGTT results indicating the development of IFG and/or IGT was provided to participants reaching those endpoints. Thus, our present findings suggest that the mere notification of incident prediabetes status may trigger beneficial changes in glycemia and body size in AAs and EAs with parental history of T2DM.

The mechanism(s) for the observed benefits in glycemia, glucose tolerance, and adiposity following notification of incident prediabetes status are unclear but could have involved self-directed lifestyle modification. To explore such a mechanism, we analyzed changes in self-reported dietary and physical activity behaviors in the 2 comparison groups of participants across the 18-month interval between conclusion of the POP-ABC study and initiation of the PROP-ABC study. We found that FHQ scores decreased in both the prediabetes and control groups (indicating healthier eating patterns), but the improvement was significantly greater in the prediabetes group. Similarly, participants in the prediabetes group reported a significant 6 MET-hr/wk greater physical activity than did those in the control group. These behavioral alterations, if sustained, could explain the glycemic and weight benefits observed in the prediabetes group. In addition to self-directed behavioral changes, it is possible that some participants may have discussed their prediabetes status with their primary care providers and may have received lifestyle counseling outside our study.

Did the Hawthorne effect or regression to the mean play a role in our findings? Subjects enrolled in research studies may alter their behavior and produce unintended results, from the increased attention and encounters associated with research participation (Hawthorne effect).21 Usually, the Hawthorne effect dissipates within approximately 4 months or once study procedures cease.22,23 Notably, our POP-ABC study had a follow-up period of 5.5 years (mean, 2.62 years) and the interval between end of study and retesting of participants was 18 months. Thus, it is unlikely that our present findings could be explained by the Hawthorne effect. Moreover, there is no reason why any Hawthorne effect would be restricted to the prediabetes group. The statistical phenomenon of regression to the mean describes the tendency of individuals with outlier values on a given measure to have spontaneously lower values on retesting, without any intervention. The use of contemporaneous measurements in a matched control group, as was done in the present study, usually obviates the risk of misinterpretation due to regression to the mean.24,25

Two previous national surveys had reported discordant findings on the impact of awareness of prediabetes status on health behavior.14,15 Data from the 2006 National Health Interview Survey showed that of the ∼ 4% of US adults who had been told that they had prediabetes, 68% reported active attempts to lose or control weight, 55% reported increased physical activity, 60% reported less fat consumption, and 42% reported trying all 3 approaches.14 In a different report, investigators analyzed data on 24-hour dietary recall, self-reported diabetes and prediabetes awareness status, and FPG and HbA1c values from the 2005 to 2010 National Health and Nutrition Examination Survey.15 Persons unaware of diabetes and prediabetes were identified by FPG <126 mg/dL or HbA1c <6.5% and FPG 100 mg/dL to 125 mg/dL or HbA1c of 5.7–6.4%, respectively.15 People with diagnosed diabetes reported consumption of less carbohydrates and more protein compared with those with undiagnosed diabetes.15 However, the authors observed no significant differences in macronutrient intake by awareness of prediabetes status.15 The conclusion from the 2005 to 2010 National Health and Nutrition Examination Survey data was that knowledge of glycemic status induced healthier dietary patterns for people with diabetes but not those with prediabetes. Unlike the cross-sectional surveys based on self-reported prediabetes status, our prospective study used a rigorous ascertainment of incident prediabetes status, using OGTT and independent adjudication. Thus, the mechanism of becoming aware of incident prediabetes in the POP-ABC study was the documentation that a participant's FPG and/or 2hrPG values had drifted upward from normal glucose regulation to prediabetes (IFG and/or IGT). Our findings support a beneficial impact of prediabetes awareness on health behavior and metabolic endpoints. We argue that awareness of incident prediabetes status through direct communication of measured glucose values, as was done in the POP-ABC study, was impactful in triggering behavioral change.

Remarkably, the vast majority of people with prediabetes in the general primary care population remain undiagnosed and unaware of their condition.2,14,15,26 In the 2006 National Health Interview Survey, only an estimated 4% of US adults had been told they had prediabetes.15 Although ∼34% of US adults had prediabetes in 2015, only 11.6% self-reported that they had been diagnosed with prediabetes by a health care worker.2 Awareness of and response to prediabetes among health care providers is even much lower. Analyzing HbA1c data from the 2012 National Ambulatory Medical Care Survey that targeted adults aged >45 years without diagnosed diabetes who had an HbA1c test within 90 days (N = 11,167,004 weighted visits), the prevalence of prediabetes was found to be 33.6%.26 However, <1% of patients with HbA1c results consistent with prediabetes had formal diagnosis and documentation of prediabetes in the medical records.26 Clearly, there is need for a greater awareness and early action regarding the diagnosis and management of prediabetes. Once a diagnosis is obtained, using FPG, OGTT, or HbA1c values, the clinical significance of prediabetes needs to be communicated clearly to all affected patients (6 to 8), as the present report has shown that notification of prediabetes status (even without active intervention) may trigger beneficial self-directed lifestyle modifications. In addition, current guidelines by the ADA recommend referring people with prediabetes for intensive lifestyle modification.4

Acknowledgments

All authors participated in the interpretation of the studies and review of the manuscript. SD-J, as principal investigator and guarantor of this manuscript, designed the study, analyzed data, and wrote the manuscript. IO performed statistical analysis, reviewed, and revised manuscript; and NU collected data, reviewed, and revised the manuscript. FC collected data, reviewed, and revised the manuscript.

We are indebted to the participants who volunteered for this study.

Notes

  • This article was externally peer reviewed.

  • Funding: This study was supported by Grant R01 DK067269 from the National Institutes of Health and Grant 7–07-MN-13 from the ADA, both awarded to SD-J. The funding sources had no role in the design and execution of the study, or analysis and publication of the data obtained from the study.

  • Conflict of interest: none declared.

  • To see this article online, please go to: http://jabfm.org/content/32/1/20.full.

  • Received for publication August 21, 2018.
  • Revision received September 27, 2018.
  • Accepted for publication October 2, 2018.

References

  1. 1.↵
    American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care 2002;25:742–9.
    OpenUrlFREE Full Text
  2. 2.↵
    Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2017. Available from: https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. Accessed August 2018.
  3. 3.↵
    1. Ogurtsova K,
    2. da Rocha Fernandes JD,
    3. Huang Y,
    4. et al
    . IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50.
    OpenUrlCrossRefPubMed
  4. 4.↵
    American Diabetes Association. Standards of medical care in diabetes—2018. Diabetes Care 2018;41:S1–S155.
    OpenUrlFREE Full Text
  5. 5.↵
    World Health Organization. Diabetes mellitus: report of a WHO Study Group. Tech. Rep. Ser. 1985, no. 727. Geneva, World Health Organization; 1985.
  6. 6.↵
    1. Nathan DM,
    2. Davidson MB,
    3. DeFronzo RA,
    4. et al
    . Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753–9.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Brannick B,
    2. Wynn A,
    3. Dagogo-Jack S
    . Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Exp Biol Med (Maywood) 2016;241:1323–31.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Brannick B,
    2. Dagogo-Jack S
    . Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction. Endocrinol Metab Clin North Am 2018;47:33–50.
    OpenUrl
  9. 9.↵
    1. Knowler WC,
    2. Barrett-Connor E,
    3. Fowler SE,
    4. et al
    . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Li G,
    2. Zhang P,
    3. Wang J,
    4. et al
    . Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014;2:474–80.
    OpenUrl
  11. 11.↵
    1. Lindström J,
    2. Ilanne-Parikka P,
    3. Peltonen M,
    4. Aunola S,
    5. Eriksson JG,
    6. Hemiö K
    . Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673–9.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Perreault L,
    2. Pan Q,
    3. Mather KJ,
    4. et al
    . Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243–51.
    OpenUrlCrossRefPubMed
  13. 13.↵
    Diabetes Prevention Program Research Group. Achieving weight and activity goals among Diabetes Prevention Program lifestyle participants. Obes Res 2004;12:1426–34.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Centers for Disease Control and Prevention. Self-reported prediabetes and risk-reduction activities—United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1203–5.
    OpenUrlPubMed
  15. 15.↵
    1. Bardenheier BH,
    2. Cogswell ME,
    3. Gregg EW,
    4. Williams DE,
    5. Zhang Z,
    6. Geiss LS
    . Does knowing one's elevated glycemic status make a difference in macronutrient intake? Diabetes Care 2014;37:3143–9.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Dagogo-Jack S,
    2. Edeoga E,
    3. Ebenibo S,
    4. Chapp-Jumbo E
    . Pathobiology of prediabetes in a bi-racial cohort (POP-ABC) study: baseline characteristics of enrolled subjects. J Clin Endocrinol Metab 2013;98:120–8.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Dagogo-Jack S,
    2. Edeoga C,
    3. Ebenibo S,
    4. Nyenwe E,
    5. Wan J
    ; for the Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) Research Group. Lack of racial disparity in incident prediabetes and glycemic progression among black and white offspring of parents with type 2 diabetes: the Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) Study. J Clin Endocrinol Metab 2014;99:E1078–87.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Krista AR,
    2. Shattuck AL,
    3. Henry HJ
    . Patterns of dietary behavior associated with selecting diets low in fat: reliability and validity of a behavioral approach to dietary assessment. J Am Diet Assoc 1990;90:214–20.
    OpenUrlPubMed
  19. 19.↵
    1. Kriska AM,
    2. Knowler WC,
    3. LaPorte RE,
    4. et al
    . Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990;13:401–11.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Boucher AB,
    2. Adesanya EAO,
    3. Owei I,
    4. et al
    . Dietary habits and leisure-time physical activity in relation to adiposity, dyslipidemia, and incident dysglycemia in the Pathobiology of Prediabetes in A Biracial Cohort Study. Metabolism 2015;64:1060–7.
    OpenUrl
  21. 21.↵
    1. Parsons HM
    . What Happened at Hawthorne?: new evidence suggests the Hawthorne effect resulted from operant reinforcement contingencies. Science 1974;183:922–1932.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Cizza G,
    2. Piaggi P,
    3. Rother KI,
    4. Csako G
    ; Sleep Extension Study Group. Hawthorne effect with transient behavioral and biochemical changes in a randomized controlled sleep extension trial of chronically short-sleeping obese adults: implications for the design and interpretation of clinical studies. PLoS One 2014 Aug 20;9:e104176.
    OpenUrl
  23. 23.↵
    1. McCambridge J,
    2. Witton J,
    3. Elbourne DR
    . Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol 2014;3:267–77.
    OpenUrl
  24. 24.↵
    1. Yu R,
    2. Chen L
    . The need to control for regression to the mean in social psychology studies. Front Psychol 2015;5:1574.
    OpenUrl
  25. 25.↵
    1. Linden A
    . Assessing regression to the mean effects in health care initiatives. BMC Med Res Methodol 2013;13:119.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Mainous AG,
    2. Tanner RJ,
    3. Baker R
    . Prediabetes diagnosis and treatment in primary care. J Am Board Fam Med 2016;29:283–5.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family   Medicine: 32 (1)
The Journal of the American Board of Family Medicine
Vol. 32, Issue 1
January-February 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels
Ibiye Owei, Nkiru Umekwe, Fatoumatta Ceesay, Samuel Dagogo-Jack
The Journal of the American Board of Family Medicine Jan 2019, 32 (1) 20-27; DOI: 10.3122/jabfm.2019.01.180242

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels
Ibiye Owei, Nkiru Umekwe, Fatoumatta Ceesay, Samuel Dagogo-Jack
The Journal of the American Board of Family Medicine Jan 2019, 32 (1) 20-27; DOI: 10.3122/jabfm.2019.01.180242
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study
  • Turning Points as Opportunities to Partner with Patients Living with type 2 Diabetes or Prediabetes
  • Designing and Evaluating a Prediabetes Shared Decision Aid
  • Conversations, Communication and Counseling Are Key Family Medicine Tactics to Improve Patient Health
  • Google Scholar

More in this TOC Section

  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Successful Implementation of Integrated Behavioral Health
Show more Original Research

Similar Articles

Keywords

  • Health Behavior
  • Life Style
  • Prediabetes

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire